Direct intra-tumoral injection of zinc-acetate halts tumor growth in a xenograft model of prostate cancer

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Shah, Maulik R ^a,b   Kriedt, Christopher L ^b   Lents, Nathan H ^c   Hoyer, Mary K ^b   Jamaluddin, Nimah ^b   Klein, Claudette ^b   Baldassare, Joseph ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c JOHN JAY COLLEGE OF CRIMINAL JUSTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ZINC ACETATE; ZINC CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CELL DEATH; CELL KILLING; CELL STRAIN LNCAP; CLINICAL PROTOCOL; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROSTATE CANCER; REPEATED DRUG DOSE; SINGLE DRUG DOSE; XENOGRAFT; ANIMAL; CELL PROLIFERATION; DRUG SCREENING; INTRALESIONAL DRUG ADMINISTRATION; MALE; MOUSE MUTANT; NEOPLASM; NONOBESE DIABETIC MOUSE; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL CULTURE;

ANIMALS; CELL PROLIFERATION; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS; ZINC ACETATE;

EID: 68149123651     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-84     Document Type: Article

References (27)

1. Cancer statistics digest. Mortality trend of prostate, breast, uterus, ovary, bladder and "kidney and other urinary tract" cancer in Japan by birth cohort. K Kamo T Sobue, Jpn J Clin Oncol 2004 34 9 561 563 10.1093/jjco/hyh100 15466832
2. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models. CM Springate JK Jackson ME Gleave HM Burt, Cancer Chemother Pharmacol 2005 56 3 239 247 10.1007/s00280-004-0997-5 15864591
3. Zinc: the biology and therapeutics of an ion. AS Prasad, Ann Intern Med 1996 125 2 142 144 8678369
4. Nutrition and prostate cancer: a case-control study. MY Heshmat L Kaul J Kovi MA Jackson AG Jackson GW Jones M Edson JP Enterline RG Worrell SL Perry, Prostate 1985 6 1 7 17 10.1002/pros.2990060103 4038555
5. Zinc supplement use and risk of prostate cancer. MF Leitzmann MJ Stampfer K Wu GA Colditz WC Willett EL Giovannucci, J Natl Cancer Inst 2003 95 13 1004 1007 12837837 (Pubitemid 36896718)
6. Effect of zinc on prostatic tumorigenicity in nude mice. P Feng TL Li ZX Guan RB Franklin LC Costello, Ann N Y Acad Sci 2003 1010 316 320 10.1196/annals.1299.056 15033742
7. Zinc causes a shift toward citrate at equilibrium of the m-aconitase reaction of prostate mitochondria. LC Costello RB Franklin Y Liu MC Kennedy, J Inorg Biochem 2000 78 2 161 165 10.1016/S0162-0134(99)00225-1 10766339
8. Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. RB Franklin J Ma J Zou Z Guan BI Kukoyi P Feng LC Costello, J Inorg Biochem 2003 96 23 435 442 10.1016/S0162-0134(03)00249-6 12888280
9. hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands. MM Desouki J Geradts B Milon RB Franklin LC Costello, Mol Cancer 2007 6 37 17550612 10.1186/1476-4598-6-37
10. Cancer of the prostate: early diagnosis by zinc and hormone analysis? FK Habib MK Mason PH Smith SR Stitch, Br J Cancer 1979 39 6 700 704 87214 (Pubitemid 9200736)
11. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. LC Costello RB Franklin, Prostate 1998 35 4 285 296 10.1002/(SICI)1097-0045(19980601)35:4<285::AID-PROS83.0.CO;2-F 9609552 (Pubitemid 28235130)
12. Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer. LC Costello RB Franklin P Feng, Mitochondrion 2005 5 3 143 153 10.1016/j.mito.2005.02.001 16050980
13. Inhibitory effect of zinc on human prostatic carcinoma cell growth. JY Liang YY Liu J Zou RB Franklin LC Costello P Feng, Prostate 1999 40 3 200 207 10.1002/(SICI)1097-0045(19990801)40:3<200::AID-PROS83.0.CO;2-3 10398282 (Pubitemid 29334868)
14. Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. LC Costello P Feng B Milon M Tan RB Franklin, Prostate Cancer Prostatic Dis 2004 7 2 111 117 10.1038/sj.pcan.4500712 15175662
15. Dietary zinc and prostate cancer risk: a case-control study from Italy. S Gallus R Foschi E Negri R Talamini S Franceschi M Montella V Ramazzotti A Tavani L Dal Maso C La Vecchia, Eur Urol 2007 52 4 1052 1056 10.1016/j.eururo.2007.01.094 17292532
16. Effects of zinc on SN56 cholinergic neuroblastoma cells. A Ronowska S Gul-Hinc H Bielarczyk T Pawelczyk A Szutowicz, J Neurochem 2007 103 3 972 983 10.1111/j.1471-4159.2007.04786.x 17662047
17. Extracellular zinc and zinc-citrate, acting through a putative zinc-sensing receptor, regulate growth and survival of prostate cancer cells. N Dubi L Gheber D Fishman I Sekler M Hershfinkel, Carcinogenesis 2008 29 9 1692 1700 10.1093/carcin/bgn027 18310092
18. Zinc as an anti-tumor agent in prostate cancer and in other cancers. RB Franklin LC Costello, Arch Biochem Biophys 2007 463 2 211 217 17400177 10.1016/j.abb.2007.02.033
19. Cell lines used in prostate cancer research: a compendium of old and new lines part 1. RE Sobel MD Sadar, J Urol 2005 173 2 342 359 10.1097/01.ju. 0000141580.30910.57 15643172
20. Identification of genes expressed differentially by LNCaP or PC-3 prostate cancer cell lines. M Yang M Loda AJ Sytkowski, Cancer Res 1998 58 16 3732 3735 9721886 (Pubitemid 28376576)
21. Effect of intraperitoneal administration of zinc on C57/6J mouse liver a light microscopic study. BH Bay MC Wang GW Yip, Okajimas Folia Anat Jpn 1998 74 6 279 291 9584519
22. Zinc metabolism and homeostasis: the application of tracer techniques to human zinc physiology. NE Krebs KM Hambidge, Biometals 2001 14 34 397 412 10.1023/A:1012942409274 11831468
23. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer. P Dahm LL Yeung SS Chang MS Cookson, J Urol 2008 180 2 451 459 10.1016/j.juro.2008.04.004 18550100
24. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. LC Costello RB Franklin, Mol Cancer 2006 5 17 16700911 10.1186/1476-4598-5-17
25. Zinc in the human prostate gland: normal, hyperplastic and cancerous. V Zaichick TV Sviridova SV Zaichick, Int Urol Nephrol 1997 29 5 565 574 10.1007/BF02552202 9413764
26. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. KK Singh MM Desouki RB Franklin LC Costello, Mol Cancer 2006 5 14 16595004 10.1186/1476-4598-5-14
27. The involvement of Bax in zinc-induced mitochondrial apoptogenesis in malignant prostate cells. P Feng T Li Z Guan RB Franklin LC Costello, Mol Cancer 2008 7 25 18331646 10.1186/1476-4598-7-25